The ACVD task force on canine atopic dermatitis (XIV): clinical manifestations of canine atopic dermatitis.
about
Canine atopic dermatitis: detailed guidelines for diagnosis and allergen identificationEvidence-based veterinary dermatology: a systematic review of the pharmacotherapy of canine atopic dermatitisUse of ImageJ software for histomorphometric evaluation of normal and severely affected canine ear canalsOwner assessment of pruritus and gastrointestinal signs in apparently healthy dogs with no history of cutaneous or noncutaneous disease.Genome-wide linkage study of atopic dermatitis in West Highland White Terriers.Inhibitory effects of interleukin-10 plasmid DNA on the development of atopic dermatitis-like skin lesions in NC/Nga mice.Two loci on chromosome 5 are associated with serum IgE levels in Labrador retrievers.Ceruminal diffusion activities and ceruminolytic characteristics of otic preparations - an in-vitro studyPrevalence of and risk factors for increased serum levels of allergen-specific IgE in a population of Norwegian dogs.Genome-wide analysis in German shepherd dogs reveals association of a locus on CFA 27 with atopic dermatitis.A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client-owned dogs with atopic dermatitis.Canine atopic dermatitis: validation of recorded diagnosis against practice records in 335 insured Swedish dogsA blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs.Multiple regulatory variants located in cell type-specific enhancers within the PKP2 locus form major risk and protective haplotypes for canine atopic dermatitis in German shepherd dogs.Evaluation of the effect of a 0.0584% hydrocortisone aceponate spray on clinical signs and skin barrier function in dogs with atopic dermatitis.A systematic review and meta-analysis of the efficacy and safety of cyclosporin for the treatment of atopic dermatitis in dogs.IL-31-induced pruritus in dogs: a novel experimental model to evaluate anti-pruritic effects of canine therapeuticsThe role of mast cells in atopy: what can we learn from canine models? A thorough review of the biology of mast cells in canine and human systems.Effects of cetirizine in dogs with chronic atopic dermatitis: a randomized, double blind, placebo-controlled trial.Efficacy of dimetinden and hydroxyzine/chlorpheniramine in atopic dogs: a randomised, controlled, double-blinded trial.Current evidence of skin barrier dysfunction in human and canine atopic dermatitis.A systematic review of randomized controlled trials for prevention or treatment of atopic dermatitis in dogs: 2008-2011 update.Treating canine atopic dermatitis with unsaturated fatty acids: the role of mast cells and potential mechanisms of action.Review: Clinical and histological manifestations of canine atopic dermatitis.Demography and disorders of German Shepherd Dogs under primary veterinary care in the UK.Canine atopic dermatitis: breed risk in Australia and evidence for a susceptible clade.Histologic morphology and involucrin, filaggrin, and keratin expression in normal canine skin from dogs of different breeds and coat types.The effect of long-term feeding of skin barrier-fortified diets on the owner-assessed incidence of atopic dermatitis symptoms in Labrador retrievers.Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis.The results of intradermal skin tests (IDST) in dogs with atopic dermatitis from the Lublin voivodeship.A canine model of cutaneous late-phase reactions: prednisolone inhibition of cellular and cytokine responses.Validation of the Canine Atopic Dermatitis Extent and Severity Index (CADESI)-4, a simplified severity scale for assessing skin lesions of atopic dermatitis in dogs.Characterisation of dog sensitisation to grass pollen in western France from 1999 to 2010.Essential fatty acids supplementation in different-stage atopic dogs fed on a controlled diet.Efficacy of cyclosporin in the treatment of atopic dermatitis in dogs--combined results from two veterinary dermatology referral centres.Gender aspects in allergies of pets – A secondary publication and update.Gender aspects in allergies of pets - A secondary publication and update.Long-term effects of intralymphatic immunotherapy (ILIT) on canine atopic dermatitis.Evaluation of the bacterial microflora of the conjunctival sac of healthy dogs and dogs with atopic dermatitis.A blinded, randomized clinical trial evaluating the efficacy and safety of lokivetmab compared to ciclosporin in client-owned dogs with atopic dermatitis.
P2860
Q26799647-37DDB502-1CD6-4085-95F0-53D854C4FDE2Q28196384-BD526113-C246-43EA-9B4B-0AD5F7C06B55Q28364367-05F307B3-5FF6-489C-88CE-5824FC718A10Q33465582-712C4151-3072-4892-851C-CAD21ABEA5B8Q33879024-413C6939-9761-4BB4-B358-7A179668CBE1Q34075763-DEB9FC3B-696B-48ED-96C6-A00BF7EB0ABBQ34312253-EF3C9509-53FD-4800-A699-D37DCC53E647Q34662631-BD21EE10-3771-4CD4-BB07-F60274775C80Q34685930-F79B5D61-569C-4EFE-BCA6-000D20DFE476Q34720303-1372E036-8535-41E3-BD09-6CD3E70B6C9DQ34866838-4D4E5EDF-003B-4A6A-9FC6-7E5F9E3075E9Q35005628-7A604725-D384-4B4B-9276-D60FB3082740Q35194645-383C0AA8-FA62-43A6-BB02-E2FBFFCBE568Q36064293-A4841D43-9494-4B83-877B-C83382E51DA8Q36066892-A7B1FE78-821E-49B5-B07C-B4166DE140BCQ36367867-094EC6A8-60F3-4484-BEC7-8908DB42B051Q36533156-2FC33956-2193-4E51-8195-49D99037AFBEQ36654416-09DD1F2F-3F9E-417A-9A96-FC65A1902C92Q37547905-828840AE-7309-49A0-9A84-BF707E709228Q37576555-C89E2AC0-B78F-4AF2-8C2C-EDBBFE7D0990Q37854092-244C6621-077D-4932-B2DC-184258322619Q38075150-FFC8EBAE-57D3-4529-BA6B-CBF5427231CDQ38195915-D871B7A1-AC06-4A8E-8D61-50263BDCD997Q38353279-4ED5BEA2-9A78-49DE-83FE-5F78CD218369Q38645398-BF088ABA-D24E-426D-A591-68E6551921C6Q38836628-73A21AC0-8A5C-44B2-B6CF-75E43F7C938FQ40042057-1103E029-0906-4663-B5D7-E7BEDF071AB2Q41834886-AA2BEC07-7F65-4883-A981-F494A64B9A9EQ43067638-B55F45DD-1B69-4010-9793-5BD2D48821D2Q43417744-4EA8F4A6-763D-40AF-9D89-D54FAC5EEE5FQ44864686-07D9667D-C4C4-4192-B868-852BF7B0B716Q44872320-C8945C2A-9751-4707-92B6-E30743C29075Q46162410-967A2A83-DF66-4427-97D5-C69BC970FFB3Q46401726-3E3A2D38-393F-49FA-9F7A-87A1151213AAQ46565818-396BCF59-3DC2-4B50-B86D-8119C4B273EFQ47151484-9096AEF9-A815-4385-B919-A8A8FA010A98Q47200085-07BB93A3-0F8D-41A7-807A-2C22671491EAQ48255235-F3FD0FBD-0551-45AC-A243-0AEAA2AA3D1FQ48267182-95437038-6D43-423E-8FB1-997EA41E33BCQ48347863-0B90F453-1E4A-4B90-9F03-D62A160A06B4
P2860
The ACVD task force on canine atopic dermatitis (XIV): clinical manifestations of canine atopic dermatitis.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The ACVD task force on canine ...... s of canine atopic dermatitis.
@ast
The ACVD task force on canine ...... s of canine atopic dermatitis.
@en
type
label
The ACVD task force on canine ...... s of canine atopic dermatitis.
@ast
The ACVD task force on canine ...... s of canine atopic dermatitis.
@en
prefLabel
The ACVD task force on canine ...... s of canine atopic dermatitis.
@ast
The ACVD task force on canine ...... s of canine atopic dermatitis.
@en
P1476
The ACVD task force on canine ...... ns of canine atopic dermatitis
@en
P2093
C E Griffin
P304
P356
10.1016/S0165-2427(01)00346-4
P577
2001-09-01T00:00:00Z